Pulmonary Hypertension in Parenchymal Lung Disease

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.

Original languageEnglish (US)
Pages (from-to)461-474
Number of pages14
JournalHeart Failure Clinics
Volume8
Issue number3
DOIs
StatePublished - Jul 2012

Fingerprint

Pulmonary Hypertension
Lung Diseases
Hypoventilation
Systemic Vasculitis
Interstitial Lung Diseases
Sleep Apnea Syndromes
Sarcoidosis
Vasoconstriction
Focus Groups
Chronic Obstructive Pulmonary Disease
Lung

Keywords

  • Chronic obstructive pulmonary disease
  • Idiopathic pulmonary fibrosis
  • Interstitial lung disease
  • Pulmonary hypertension

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Pulmonary Hypertension in Parenchymal Lung Disease. / Ruggiero, Rosechelle M.; Bartolome, Sonja; Torres, Fernando.

In: Heart Failure Clinics, Vol. 8, No. 3, 07.2012, p. 461-474.

Research output: Contribution to journalArticle

@article{e338d3ae8c68485697e6dc4afa694222,
title = "Pulmonary Hypertension in Parenchymal Lung Disease",
abstract = "The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.",
keywords = "Chronic obstructive pulmonary disease, Idiopathic pulmonary fibrosis, Interstitial lung disease, Pulmonary hypertension",
author = "Ruggiero, {Rosechelle M.} and Sonja Bartolome and Fernando Torres",
year = "2012",
month = "7",
doi = "10.1016/j.hfc.2012.04.010",
language = "English (US)",
volume = "8",
pages = "461--474",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Pulmonary Hypertension in Parenchymal Lung Disease

AU - Ruggiero, Rosechelle M.

AU - Bartolome, Sonja

AU - Torres, Fernando

PY - 2012/7

Y1 - 2012/7

N2 - The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.

AB - The pathophysiology of pulmonary hypertension (PH) in parenchymal lung diseases is partially related to hypoxic pulmonary vasoconstriction. PH treatment is controversial for these patients. This article focuses on group III PH, namely PH attributable to lung diseases and/or hypoxia. Group III includes chronic obstructive pulmonary disease and interstitial lung diseases, the most common parenchymal lung diseases associated with PH. It also includes sleep-disordered breathing and hypoventilation from any cause. Other parenchymal lung diseases associated with PH, namely sarcoidosis and systemic vasculitides (group V), are discussed. The data describing PH in specific parenchymal diseases are reviewed.

KW - Chronic obstructive pulmonary disease

KW - Idiopathic pulmonary fibrosis

KW - Interstitial lung disease

KW - Pulmonary hypertension

UR - http://www.scopus.com/inward/record.url?scp=84863088716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863088716&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2012.04.010

DO - 10.1016/j.hfc.2012.04.010

M3 - Article

C2 - 22748906

AN - SCOPUS:84863088716

VL - 8

SP - 461

EP - 474

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 3

ER -